微芯生物
(688321)
| 流通市值：87.97亿 | | | 总市值：87.97亿 |
| 流通股本：4.43亿 | | | 总股本：4.43亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 840,505,861.85 | 543,229,019.55 | 257,038,676.31 | 910,061,840.72 |
| 营业总成本 | 735,532,472.55 | 460,754,874.42 | 224,552,523.96 | 846,023,589.62 |
| 其他经营收益 | | | | |
| 营业利润 | 91,734,735.24 | 73,003,861.64 | 28,896,419.94 | 50,111,980.97 |
| 利润总额 | 91,419,172.71 | 72,726,465.57 | 28,652,328.91 | 50,052,450.53 |
| 净利润 | 91,174,889.77 | 71,380,590.11 | 28,271,869.04 | 50,959,162.56 |
| 每股收益 | | | | |
| 其他综合收益 | -1,568,733.9 | -1,242,316.45 | -673,116.67 | -972,852.61 |
| 综合收益总额 | 89,606,155.87 | 70,138,273.66 | 27,598,752.37 | 49,986,309.95 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,821,559,202.42 | 1,943,953,488.21 | 2,064,481,235.6 | 1,180,388,674.71 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,669,439,450.44 | 2,655,892,021.68 | 2,517,451,590.7 | 2,470,107,721.12 |
| 资产总计 | 4,490,998,652.86 | 4,599,845,509.89 | 4,581,932,826.3 | 3,650,496,395.83 |
| 流动负债: | | | | |
| 流动负债合计 | 625,114,836.17 | 816,911,740.03 | 805,157,918.65 | 843,902,453.31 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,313,095,362.58 | 1,232,962,753.41 | 1,192,189,750.85 | 1,180,769,878.5 |
| 负债合计 | 1,938,210,198.75 | 2,049,874,493.44 | 1,997,347,669.5 | 2,024,672,331.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,552,788,454.11 | 2,549,971,016.45 | 2,584,585,156.8 | 1,625,824,064.02 |
| 股东权益合计 | 2,552,788,454.11 | 2,549,971,016.45 | 2,584,585,156.8 | 1,625,824,064.02 |
| 负债和股东权益合计 | 4,490,998,652.86 | 4,599,845,509.89 | 4,581,932,826.3 | 3,650,496,395.83 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 872,109,797.73 | 565,594,653.92 | 270,052,993.79 | 878,200,278.36 |
| 经营活动现金流出小计 | 749,252,041.9 | 476,229,580.38 | 245,709,035.68 | 781,234,920.07 |
| 经营活动产生的现金流量净额 | 122,857,755.83 | 89,365,073.54 | 24,343,958.11 | 96,965,358.29 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,486,589,372.34 | 1,213,467,782.1 | 310,160,743.12 | 1,667,499,604.24 |
| 投资活动现金流出小计 | 2,921,750,278.45 | 1,725,658,372.71 | 1,004,357,608.99 | 1,885,115,121.58 |
| 投资活动产生的现金流量净额 | -435,160,906.11 | -512,190,590.61 | -694,196,865.87 | -217,615,517.34 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,395,499,997.44 | 1,268,863,997.44 | 1,048,863,997.44 | 491,902,465 |
| 筹资活动现金流出小计 | 707,788,997.85 | 485,493,922.45 | 135,646,418.42 | 364,302,314.7 |
| 筹资活动产生的现金流量净额 | 687,710,999.59 | 783,370,074.99 | 913,217,579.02 | 127,600,150.3 |
| 汇率变动对现金及现金等价物的影响 | -1,869,250.84 | -1,393,957.95 | -788,180.1 | -807,474.93 |
| 现金及现金等价物净增加额 | 373,538,598.47 | 359,150,599.97 | 242,576,491.16 | 6,142,516.32 |
| 期末现金及现金等价物余额 | 602,221,523.65 | 587,833,525.15 | 471,259,416.34 | 228,682,925.18 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 359,150,599.97 | - | 6,142,516.32 |
最新报告期：2026-08-27| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 方正证券 | 许睿,李霁阳 | 0.30 | 0.56 | 0.81 | 2026-08-27 |
| 中信建投 | 沈毅,袁清慧,魏佳奥 | 0.29 | 0.47 | 0.60 | 2026-08-25 |
| 财通证券 | 华挺 | 0.29 | 0.45 | 0.81 | 2026-08-20 |